Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?
07:15am, Friday, 15'th Aug 2025
Pfizer (PFE -0.18%) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine resulted in the business posting record sales and profits in 2022.
3 Cheap Dividend Stocks With Excellent Yields
01:01pm, Thursday, 14'th Aug 2025
When it comes to picking stocks to buy in 2025, you need to look for stability and minimal volatility. The market has seen a lot of ups and downs this year, and building a portfolio that is resilient
3 Cheap Dividend Stocks With Excellent Yields
11:13am, Thursday, 14'th Aug 2025
When it comes to picking stocks to buy in 2025, you need to look for stability and minimal volatility. The market has seen a lot of ups and downs this year, and building a portfolio that is resilient
3 Dividend Stocks That Can Make You $1 Million By 2030
08:07am, Thursday, 14'th Aug 2025
Dividend stocks are a time-tested way to retire or protect your portfolio if you are already retired.
PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?
01:56pm, Wednesday, 13'th Aug 2025
Pfizer's new and acquired drugs record sales of $4.7B in H1 as COVID-products related volatility eases.
FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age
10:09am, Wednesday, 13'th Aug 2025
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
04:51am, Wednesday, 13'th Aug 2025
Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide.
FDA may pull authorization of Pfizer's Covid vaccine for children under 5
02:53pm, Tuesday, 12'th Aug 2025
The Food and Drug Administration is weighing revoking its authorization of Pfizer's Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed to CNBC. The move could leave many
Pfizer's combination therapy improves survival in bladder cancer trial
05:43am, Tuesday, 12'th Aug 2025
Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in patients with muscle-invasive bladder cancer when administered before and
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
05:30am, Tuesday, 12'th Aug 2025
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive topline results from the Phas
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
09:16pm, Monday, 11'th Aug 2025
Wondering how well you'd have done if you'd invested in pharmaceutical giant Pfizer (PFE 0.06%) three years ago and hung on? Well, I'm afraid the answer isn't pretty: If you'd investing $1,000 in Pfiz
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
08:15pm, Monday, 11'th Aug 2025
Pfizer (PFE 0.06%) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to follow up on the succes
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
01:55pm, Monday, 11'th Aug 2025
View Preview
Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results?
10:16am, Monday, 11'th Aug 2025
Pfizer posts strong Q2 earnings and raises EPS outlook, with oncology growth and new drugs offsetting looming headwinds.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 11'th Aug 2025
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
